373 related articles for article (PubMed ID: 28765266)
1. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
Roy R; Dagher A; Butterfield C; Moses MA
Mol Cancer Res; 2017 Nov; 15(11):1608-1622. PubMed ID: 28765266
[TBL] [Abstract][Full Text] [Related]
2. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
3. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
[TBL] [Abstract][Full Text] [Related]
4. ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions.
Eckert MA; Santiago-Medina M; Lwin TM; Kim J; Courtneidge SA; Yang J
J Cell Sci; 2017 Jun; 130(12):2036-2048. PubMed ID: 28468988
[TBL] [Abstract][Full Text] [Related]
5. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
[TBL] [Abstract][Full Text] [Related]
6. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer.
Wu X; Yang T; Liu X; Guo JN; Xie T; Ding Y; Lin M; Yang H
Tumour Biol; 2016 Apr; 37(4):5493-501. PubMed ID: 26566627
[TBL] [Abstract][Full Text] [Related]
7. ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells.
Wang X; Wang Y; Gu J; Zhou D; He Z; Wang X; Ferrone S
Sci Rep; 2017 Aug; 7(1):9687. PubMed ID: 28852196
[TBL] [Abstract][Full Text] [Related]
8. An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.
Luo ML; Zhou Z; Sun L; Yu L; Sun L; Liu J; Yang Z; Ran Y; Yao Y; Hu H
Cancer Lett; 2018 May; 422():118-128. PubMed ID: 29476791
[TBL] [Abstract][Full Text] [Related]
9. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
10. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
[TBL] [Abstract][Full Text] [Related]
11. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.
Zhou X; Yan T; Huang C; Xu Z; Wang L; Jiang E; Wang H; Chen Y; Liu K; Shao Z; Shang Z
J Exp Clin Cancer Res; 2018 Oct; 37(1):242. PubMed ID: 30285793
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
13. A novel bisindole-PBD conjugate inhibits angiogenesis by regulating STAT3 and VEGF in breast cancer cells.
Sarma P; Ramaiah MJ; Pal D; Bhadra U; Pal Bhadra M
Life Sci; 2016 Apr; 151():264-276. PubMed ID: 26979778
[TBL] [Abstract][Full Text] [Related]
14. C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2/STAT3.
Zhang Q; Xu F; Shi Y; Chen YW; Wang HP; Yu X; Li Y
Cell Biol Int; 2017 Aug; 41(8):854-862. PubMed ID: 28544312
[TBL] [Abstract][Full Text] [Related]
15. Modulation of miR29a improves impaired post-ischemic angiogenesis in hyperglycemia.
Chen L; Okeke E; Ayalew D; Wang D; Shahid L; Dokun AO
Exp Biol Med (Maywood); 2017 Aug; 242(14):1432-1443. PubMed ID: 28637396
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 induces a pro-angiogenic profile in chronic lymphocytic leukemia cells.
Aguilera-Montilla N; Bailón E; Ugarte-Berzal E; Uceda-Castro R; Prieto-Solano M; García-Martínez E; Samaniego R; Van den Steen PE; Opdenakker G; García-Marco JA; García-Pardo A
Biochem Biophys Res Commun; 2019 Nov; 520(1):198-204. PubMed ID: 31585732
[TBL] [Abstract][Full Text] [Related]
17. HOXB7: a key factor for tumor-associated angiogenic switch.
Carè A; Felicetti F; Meccia E; Bottero L; Parenza M; Stoppacciaro A; Peschle C; Colombo MP
Cancer Res; 2001 Sep; 61(17):6532-9. PubMed ID: 11522651
[TBL] [Abstract][Full Text] [Related]
18. ADAM12 redistributes and activates MMP-14, resulting in gelatin degradation, reduced apoptosis and increased tumor growth.
Albrechtsen R; Kveiborg M; Stautz D; Vikeså J; Noer JB; Kotzsh A; Nielsen FC; Wewer UM; Fröhlich C
J Cell Sci; 2013 Oct; 126(Pt 20):4707-20. PubMed ID: 24006261
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
20. [Effects of JAK2/STAT3 signaling pathway on angiogenesis in non-small cell lung cancer].
Zhao M; Liu F; Wang JY; Zhang WY; Gao FH; Jiang B
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):375-81. PubMed ID: 21418908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
